In addition, albeit only in one reported case, multiple intraventricular injections of CAR‐T cells targeting IL‐13Rα2 completely regressed recurrent multifocal GBM,59 indicating the importance of considering this administration route. The gene discussed is IL13RA2; the disease is glioblastoma.